Nonendothelial Mesenchymal Cell–Derived MCP-1 Is Required for FGF-2–Mediated Therapeutic Neovascularization: Critical Role of the Inflammatory/Arteriogenic Pathway

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1161/01.ATV.0000244684.23499.bfPMID 16960104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression.

  2006cited by this paper
• Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A.

  2005cited by this paper
• Collateral Artery Growth (Arteriogenesis) After Experimental Arterial Occlusion Is Impaired in Mice Lacking CC-Chemokine Receptor-2

  2004cited by this paper
• Bone marrow-Derived Cells Do Not Incorporate Into the Adult Growing Vasculature

  2004cited by this paper
• Essential Role of PDGFR&agr;-p70S6K Signaling in Mesenchymal Cells During Therapeutic and Tumor Angiogenesis In Vivo: Role of PDGFR&agr; During Angiogenesis

  2004cited by this paper
• Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis.

  2004cited by this paper
• Involvement of the Fibroblast Growth Factor System in Adaptive and Chemokine-Induced Arteriogenesis

  2003cited by this paper
• VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic: Evidence for a Monocyte-Mediated Mechanism

  2003cited by this paper
• Molecular Mechanism and Role of Endothelial Monocyte Chemoattractant Protein-1 Induction by Vascular Endothelial Growth Factor

  2003cited by this paper
• Angiogenesis in health and disease

  2003cited by this paper
• Importance of Monocyte Chemoattractant Protein-1 Pathway in Neointimal Hyperplasia After Periarterial Injury in Mice and Monkeys

  2002cited by this paper
• Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E–Knockout Mice

  2002cited by this paper
• Blood monocyte concentration is critical for enhancement of collateral artery growth.

  2002cited by this paper
• Angiogenic Gene Therapy for Experimental Critical Limb Ischemia: Acceleration of Limb Loss by Overexpression of Vascular Endothelial Growth Factor 165 but not of Fibroblast Growth Factor-2

  2002cited by this paper
• Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats.

  2002cited by this paper
• Lysophosphatidylcholine Stimulates Monocyte Chemoattractant Protein-1 Gene Expression in Rat Aortic Smooth Muscle Cells

  2002cited by this paper
• Fibroblast Growth Factor-2 Determines Severity of Joint Disease in Adjuvant-Induced Arthritis in Rats

  2002cited by this paper
• Time course of arteriogenesis following femoral artery occlusion in the rabbit.

  2001cited by this paper
• Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.

  2000cited by this paper
• Acidosis inhibits endothelial cell apoptosis and function and induces basic fibroblast growth factor and vascular endothelial growth factor expression.

  2000cited by this paper
• Anti‐monocyte chemoattractant protein‐1 gene therapy inhibits vascular remodeling in rats: blockade of MCP‐1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

  2000cited by this paper
• Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney.

  1999cited by this paper
• Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells.

  1999cited by this paper
• VEGF gene delivery to muscle: potential role for vasculogenesis in adults.

  1998cited by this paper
• Mouse model of angiogenesis.

  1998cited by this paper
• Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb.

  1998cited by this paper
• Chemokines.

  1997cited by this paper
• Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion.

  1997cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Fluid shear stress induces a biphasic response of human monocyte chemotactic protein 1 gene expression in vascular endothelium.

  1994cited by this paper
• Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor.

  1990cited by this paper
• Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line

  year unknowncited by this paper

• Design of a dual-function agent by fusing a designed anti-VEGF-A binder and CPG-2 enzyme

  2023cites this paper
• Regenerative Effect of Umbilical Cord-Derived Mesenchymal Stromal Cells in a Rat Model of Established Limb Ischemia.

  2022cites this paper
• Limb functional recovery is impaired in fibroblast growth factor-2 deficient (FGF2) mice despite chronic ischemia-induced vascular growth

  2021influential citation
• Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases

  2021cites this paper
• Overcoming ischemia in the diabetic foot: Minimally invasive treatment options

  2021cites this paper
• Limb functional recovery is impaired in fibroblast growth factor-2 (FGF2) deficient mice despite chronic ischaemia-induced vascular growth

  2020cites this paper
• Fibroblast growth factor 2 exacerbates inflammation in adipocytes through NLRP3 inflammasome activation

  2020cites this paper
• VEGF-A Is Associated With the Degree of TILs and PD-L1 Expression in Primary Breast Cancer

  2020cites this paper
• Tissue Engineering of the Microvasculature.

  2019influential citation
• Induction of extracranial arteriogenesis by an arteriovenous fistula in a pig model.

  2018cites this paper
• VEGF-A/VEGFR-2 and FGF-2/FGFR-1 but not PDGF-BB/PDGFR-β play important roles in promoting immature and inflammatory intraplaque angiogenesis

  2018cites this paper
• Fibroblast Growth Factor in Extremities

  2017cites this paper
• Novel molecular targets for coronary angiogenesis and ischemic heart disease

  2017cites this paper
• Gene Therapy for Peripheral Arterial Disease and Nursing Implications: Clinical Experience on the use of Sendai Viral Vector

  2016cites this paper
• Nanoparticle drug delivery systems and their use in cardiac tissue therapy.

  2016cites this paper
• The Roles of the High and Low Molecular Weight Isoforms of Fibroblast Growth Factor 2 in Ischemia-Induced Revascularization

  2016cites this paper
• Evaluation of the clinical relevance and limitations of current pre-clinical models of peripheral artery disease.

  2016cites this paper
• Angiogenic gene therapy for refractory angina

  2016cites this paper
• Delivering therapeutics in peripheral artery disease: challenges and future perspectives.

  2016cites this paper
• CXCL14 and MCP1 are potent trophic factors associated with cell migration and angiogenesis leading to higher regenerative potential of dental pulp side population cells

  2015cites this paper
• Erratum to: CXCL14 and MCP1 are potent trophic factors associated with cell migration and angiogenesis leading to higher regenerative potential of dental pulp side population cells

  2015cites this paper
• Adequate Selection of a Therapeutic Site Enables Efficient Development of Collateral Vessels in Angiogenic Treatment With Bone Marrow Mononuclear Cells

  2015cites this paper
• Anticancer effect of rapamycin on MCF-7 via downregulation of VEGF expression

  2015cites this paper
• Therapeutic site selection is important for the successful development of collateral vessels.

  2015cites this paper
• Mechanisms of Amplified Arteriogenesis in Collateral Artery Segments Exposed to Reversed Flow Direction

  2015cites this paper
• Die Überexpression der Integrin β5-Untereinheit fördert die proangiogenetischen Fähigkeiten endothelialer Progenitorzellen

  2015cites this paper
• Identifying and Overcoming Obstacles in Angiogenic Gene Therapy for Myocardial Ischemia

  2014cites this paper
• Interactions of monocytes and platelets: implication for life.

  2014cites this paper
• Therapeutic angiogenesis: recent and future prospects of gene therapy in peripheral artery disease.

  2014cites this paper
• Impact on smooth muscle cell migration and monocyte recruitment Role of ephrinB2 expression in endothelial cells during arteriogenesis

  2013cites this paper
• Gene Therapy for Peripheral Arterial Disease Using Sendai Virus Vector: From Preclinical Studies to the Phase I/IIa Clinical Trial

  2013cites this paper
• DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa open-label dose-escalation clinical trial.

  2013cites this paper
• PHD2 regulates arteriogenic macrophages through TIE2 signalling

  2013cites this paper
• Sendai Virus Vector

  2013cites this paper
• A somatostatin analogue, octreotide, ameliorates intestinal ischemia-reperfusion injury through the early induction of heme oxygenase-1.

  2012cites this paper
• PEG-Albumin Plasma Expansion Increases Expression of MCP-1 Evidencing Increased Circulatory Wall Shear Stress: An Experimental Study

  2012cites this paper
• Angiogenic therapy for cardiac repair based on protein delivery systems

  2012cites this paper
• Role of fibroblast growth factor signaling in vascular formation and maintenance: orchestrating signaling networks as an integrated system

  2012cites this paper
• Exercise training and peripheral arterial disease.

  2012cites this paper
• Intramural coronary lipid injection induces atheromatous lesions expressing proinflammatory chemokines: implications for the development of a porcine model of atherosclerosis.

  2011cites this paper
• Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis

  2011cites this paper
• Angiogenic and lymphangiogenic cascades in the tumor microenvironment.

  2011cites this paper
• FGF-dependent regulation of VEGF receptor 2 expression in mice.

  2011cites this paper
• Leptin Augments Cerebral Hemodynamic Reserve after Three-Vessel Occlusion: Distinct Effects on Cerebrovascular Tone and Proliferation in a Nonlethal Model of Hypoperfused Rat Brain

  2011cites this paper
• An Autocrine Linkage Between Matrix Metalloproteinase-14 and Tie-2 Via Ectodomain Shedding Modulates Angiopoietin-1–Dependent Function in Endothelial Cells

  2010cites this paper
• Overexpression of Integrin &bgr;5 Enhances the Paracrine Properties of Circulating Angiogenic Cells via Src Kinase–Mediated Activation of STAT3

  2010cites this paper
• Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization.

  2010cites this paper
• Regulation of the expression balance of angiopoietin-1 and angiopoietin-2 by Shh and FGF-2

  2010cites this paper
• Mushroom-like soft fibromas on chronic leg lymphedema.

  2010cites this paper
• Chemokines in angiogenesis.

  2010cites this paper
• Targeted deletion of the inhibitory NF-kappaB p50 subunit in bone marrow-derived cells improves collateral growth after arterial occlusion.

  2010cites this paper
• Integrative Physiology/Experimental Medicine Therapeutic Neovascularization by Nanotechnology- Mediated Cell-Selective Delivery of Pitavastatin Into the Vascular Endothelium

  2009cites this paper
• CHAPTER 8I – Endothelial Cells and Angiogenesis

  2009cites this paper
• Chemokines and angiogenesis in rheumatoid arthritis.

  2009cites this paper
• Selective and sustained delivery of basic fibroblast growth factor (bFGF) for treatment of peripheral arterial disease: results of a phase I trial.

  2009cites this paper
• Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease

  2009cites this paper
• Autocrine loop between vascular endothelial growth factor (VEGF)-C and VEGF receptor-3 positively regulates tumor-associated lymphangiogenesis in oral squamoid cancer cells.

  2009cites this paper
• Life span of monocytes and platelets: importance of interactions.

  2009cites this paper
• The Role of Angiogenic Growth Factors in Arteriogenesis

  2009cites this paper
• Stretch-Induced Activation of the Transcription Factor Activator Protein-1 Controls Monocyte Chemoattractant Protein-1 Expression During Arteriogenesis

  2008cites this paper
• VEGF function for upregulation of endogenous PlGF expression during FGF-2-mediated therapeutic angiogenesis.

  2008cites this paper
• Circulating cells and cytokines in arteriogenesis

  2008cites this paper
• Fibroblast growth factor regulation of neovascularization

  2008cites this paper
• Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression Authors:

  2008influential citation
• Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression.

  2008influential citation
• Monocyte Chemoattractant Protein-1 Expression During Arteriogenesis Stretch-Induced Activation of the Transcription Factor Activator Protein-1 Controls

  2008cites this paper
• Fibroblast Growth Factor-2 in Angiogenesis

  2008cites this paper
• Chemokines and cytokines in inflammatory angiogenesis

  2008cites this paper
• Recombinant Human Bone Morphogenetic Protein-2 as an Osteoinductive Biomaterial and a Biodegradable Carrier in a Rabbit Ulnar Defect Model

  2008cites this paper
• Role of ephrinB2 expression in endothelial cells during arteriogenesis: impact on smooth muscle cell migration and monocyte recruitment.

  2008cites this paper
• Post-ischaemic neovascularization and inflammation.

  2008cites this paper
• Stimulation of collateral artery growth: travelling further down the road to clinical application

  2008cites this paper
• Therapeutic Angiogenesis

  2007cites this paper